Novo Nordisk, Arogga sign MoU to expand digital diabetes care
Novo Nordisk Pharma Ltd and Arogga Limited have signed a memorandum of understanding to improve patient access to diabetes care and authentic Novo Nordisk products through digital channels in Bangladesh.
Under the partnership, Arogga will facilitate online ordering and home delivery of Novo Nordisk products within Dhaka, ensuring cold-chain compliance. The initiative will also include QR code-based instructional materials to support correct product usage.
The companies said the collaboration aims to combine technology and accessibility while maintaining compliance standards, with a focus on improving patient convenience and continuity of care.
Keep updated, follow The Business Standard's Google news channel
From Novo Nordisk, the signing ceremony was attended by Mohammad Riad Mamun Prodhani, Managing Director, and Mahbubur Rahman, Director, Clinical, Medical and Regulatory.
Representing Arogga Limited, Rosina Mazumder, Co-Founder and Chief Executive Officer, and Yawar Mehboob, Co-Founder and Chief Scientific Officer, were present at the event.
